Regeneron Pharmaceuticals, Inc.

( )
REGN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
GILDGilead Sciences, Inc. 4.23%75.931.0%$2028.13m
AMGNAmgen, Inc. 5.15%208.481.3%$944.46m
REGNRegeneron Pharmaceuticals, Inc. 5.22%473.002.6%$802.29m
BIIBBiogen, Inc. 6.53%316.131.5%$751.59m
VRTXVertex Pharmaceuticals, Inc. 6.76%231.921.9%$564.30m
MRNAModerna, Inc. 1.43%30.480.0%$562.64m
ILMNIllumina, Inc. 2.67%276.233.5%$478.28m
ALXNAlexion Pharmaceuticals, Inc. 3.87%87.262.0%$278.63m
AAgilent Technologies, Inc. 2.84%72.741.6%$236.92m
EXASEXACT Sciences Corp. 0.92%58.4321.0%$200.66m
INCYIncyte Corp. 4.66%72.172.5%$176.73m
SGENSeattle Genetics, Inc. 5.51%115.296.1%$169.71m
BMRNBioMarin Pharmaceutical, Inc. 3.75%82.494.3%$160.87m
NVAXNovavax, Inc. 9.58%14.30114.7%$133.52m
CODXCo-Diagnostics, Inc. -10.38%8.200.0%$107.45m

Company Profile

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.